Search Results

Aug 27, 2026, 09:03 ET Your Gut Is Wrong About People More Often Than You Think -- Former FBI Agent Robin Dreeke Teaches You How to Fix It, Now on MasterClass

https://dam.masterclass.com/Share/17d6k7jh0ww73548dl28t0wne78r6g4m  Credit: Courtesy of MasterClassAbout MasterClass:MasterClass is the personalized learning

More news about: MasterClass

Aug 27, 2026, 09:00 ET /R E P E A T -- BRP Will Present its Second Quarter Fiscal Year 2027 Results/

multimedia:https://www.prnewswire.com/news-releases/r-e-p-e-a-t----brp-will-present-its-second-quarter-fiscal-year-2027-results-302852328.htmlSOURCE

More news about: BRP Inc.

Aug 27, 2026, 09:00 ET Coway Expands Its Cylindrical Airmega Lineup with The Airmega Halo, Bringing Whole-Room Purification to the Mid-Size Category

Wirecutter's Top Picks for 10 years and have won multiple awards from respected outlets, like Parents, GQ, Apartment Therapy, and more.The Coway R&D Center is Asia's largest lab dedicated to air, water and sleep technologies. A team of over 300 researchers collaborate there to design, develop and

More news about: Coway

Aug 27, 2026, 08:56 ET VEMERIX Report Reveals the True Cost of Mesotherapy Consumables and the 2026 Rules Reshaping Injector Sourcing

China, Weihai Medison combines a 2,000-square-meter Class-100K manufacturing base with the Medison Korea Joint Research Institute — a multidisciplinary R&D arm partnered with senior researchers from Seoul National and Yonsei universities and leading Korean research institutes. The VEMERIX portfolio centers

More news about: WEIHAI MEDISON (VEMERIX brand)

Aug 27, 2026, 08:40 ET /C O R R E C T I O N -- MSIG USA/

More news about: MSIG USA

Aug 27, 2026, 08:30 ET FibroBiologics Releases Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial

its business; (b) expectations regarding the initiation, progress and expected results of FibroBiologics' R&D efforts and preclinical studies; (c) the unpredictable relationship between R&D and preclinical results and clinical study results; (d) the ability of FibroBiologics to successfully prosecute

More news about: FibroBiologics, Inc.

Aug 27, 2026, 08:30 ET Assessing the Use of Non-Human Primates in Translational Research Today, Upcoming Webinar Hosted by Xtalks

session will provide pratical insight relevant to R&D strategy and investment decisions in a field facing growing public and regulatory scrutiny.Join Gourav Roy-Choudhury, PhD, DABT, Senior Director,

More news about: Xtalks

Aug 27, 2026, 08:00 ET Hankook pone rumbo al WRC ueno Rally del Paraguay 2026

clave durante todo el rally.Hankook suministrará su neumático de rally todoterreno Dynapro R213, que ofrecerá un rendimiento estable en una amplia variedad de superficies sin asfaltar. El Dynapro R213 absorbe eficazmente los impactos que se producen en este tipo de superficies, al tiempo que proporciona

More news about: Hankook Tire & Technology (Hankook)

Aug 27, 2026, 08:00 ET Four Scientists Awarded $3 Million for High-Impact Research to Advance New Answers for Tau-Driven Diseases

California, San Francisco (Awarded $750,000): This research aims to reveal the molecular heterogeneity of cell type-specific tau conformers in 4-repeat (4R) tauopathies such as PSP and CBD. Dr. Condello and his co-investigators will leverage human brain samples, stem cell models, and animal models combined

More news about: The Rainwater Charitable Foundation

Aug 27, 2026, 07:30 ET STL takes a major leap towards Decarbonisation; enabling Eco-friendly product portfolio by transitioning to 100% 'Green power'

Large enterprises collaborate with STL to build their future-ready digital infrastructure. STL's business goals are driven by customer-centricity, R&D and sustainability. Read more,

More news about: Sterlite Technologies Ltd. (STL)

Aug 27, 2026, 07:30 ET STL takes a major leap towards Decarbonisation; enabling Eco-friendly product portfolio by transitioning to 100% 'Green power'

Large enterprises collaborate with STL to build their future-ready digital infrastructure. STL's business goals are driven by customer-centricity, R&D and sustainability. Read more,

More news about: Sterlite Technologies Ltd. (STL)

Aug 27, 2026, 07:15 ET Hyperliquid Strategies Inc Reports Financial Results for the Fiscal Year Ended June 30, 2026

million in staking revenue and validator commissions from HYPE holdings.$2.7 million in interest income.$14.0 million in SG&A and R&D expenses.$305.5 million in net income.Net income primarily comprised of:$709.9 million in net unrealized gains

More news about: Hyperliquid Strategies Inc

Aug 27, 2026, 07:10 ET Biosidus zwiększa moce produkcyjne w zakresie leków biologicznych i wzmacnia globalne możliwości dostaw agalzydazy beta

BUENOS AIRES, Argentyna, 27 sierpnia 2026 r. /PRNewswire/ -- Biosidus, argentyńska firma biotechnologiczna z ponad czterdziestoletnim doświadczeniem w opracowywaniu i wytwarzaniu leków biopodobnych, poinformowała o uruchomieniu

More news about: Biosidus

Aug 27, 2026, 06:50 ET BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation

expanding the impact of advanced tissue regeneration in areas where patients continue to face significant clinical challenges," said Art Stephen, global R&D Leader of Surgery at BD. "By evaluating GalaFLEX LITE™ Scaffold in breast revision surgery for capsular contracture, we are generating clinical evidence

More news about: BD (Becton, Dickinson and Company)

Aug 27, 2026, 06:34 ET NetDragon Announces 2026 Interim Financial Results

AI Employee Matrix further enhanced overall efficiency across multiple functions, including R&D, operations and maintenance, contributing to a 23.4% YoY and 13.0% HoH decrease in segmental R&D expenses for the gaming and application services.Driven by a series of major content updates,

More news about: NetDragon Websoft Holdings Limited

Aug 27, 2026, 06:30 ET ProFound Therapeutics Receives Investment to Tackle Preeclampsia and Eclampsia

Foundation, added, "Conditions like preeclampsia and eclampsia remain chronically underdiagnosed and undertreated. With only about 1% of global healthcare R&D directed toward female-specific conditions beyond cancer, promising treatments can take over a decade to reach the women who need them most. Closing

More news about: ProFound Therapeutics

Aug 27, 2026, 04:49 ET THG India Marks One Year of Shaping Global Careers for South Asian Talent

on August 1, 2025, THG India has worked to build a multidimensional ecosystem around South Asian artists and creators—connecting artist management, A&R, recorded music, live entertainment, brand partnerships, publishing and international collaboration.During its first year, the company locked

More news about: THG India